Blood Test and Tumor Genetics Sharpen Predictions of Rectal Cancer Immunotherapy Success
New TORCH trial data show that combining SMAD4 mutation status, tumor mutational burden, and serial ctDNA with MRI assessments substantially ...
New TORCH trial data show that combining SMAD4 mutation status, tumor mutational burden, and serial ctDNA with MRI assessments substantially ...
The first prospective canine cancer screening study using next-generation sequencing liquid biopsy found that adding a blood test to routine ...
A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...
A prospectively validated urine-based proteomics test significantly outperformed PSA, MRI-based benchmarks, and risk calculators in predicting clinically significant prostate cancer ...
A major new review shows that long non-coding RNAs orchestrate the colorectal cancer tumour microenvironment, offering new biomarkers and therapeutic ...
A real-world study of over 8,500 US patients with ER-positive/HER2-negative metastatic breast cancer found that ESR1 mutation testing remains rare ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine